Peptides DB
Research-centric peptide and protocol reference hub
Study 10 of 16Sermorelin literatureSynthetic and systems biotechnology · In vitro2026

Quorum sensing-driven riboflavin-hyperproducing electroactive bacteria for enhanced bioelectricity generation from sludge: From modular optimization to process performance.

Engineering bacteria to hyperproduce riboflavin can significantly enhance bioelectricity generation from waste sludge, offering a promising strategy for sustainable energy recovery.

Read at Synthetic and systems biotechnologyAdd to compare

Where it sits

this study against the rest of the sermorelin corpus
9
Preclinical · this one
7
Observational
0
Open-label
0
Randomised
0
Reviews

Summary and findings

The study engineered a quorum sensing-driven strain of Shewanella oneidensis to hyperproduce riboflavin, enhancing bioelectricity generation from waste activated sludge. The engineered strain, SQR2, produced 269.9 mg/L riboflavin, improving current density and power output by 22.2- and 11.6-fold, respectively. This approach supports sustainable wastewater resource recovery by enhancing bioelectrochemical system performance.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
269.9 mg/L riboflavin produced under bioreactor conditions.2026

Abstract

The authors’ words, as Synthetic and systems biotechnology supplied them

Waste activated sludge (WAS) represents a significant byproduct of wastewater treatment and a renewable resource for bioenergy. Bioelectrochemical systems (BESs), which couple microbial metabolism with electrochemical processes, can directly convert the organic matter in WAS into electricity. However, their performance is often constrained by the limited extracellular electron transfer (EET) capacity of electroactive bacteria. To overcome this constraint, we designed a quorum sensing-driven synthetic strategy to create self-regulated, riboflavin-hyperproducing <i>Shewanella oneidensis</i>. By engineering an Esa quorum-sensing circuit to autonomously control riboflavin biosynthesis, coupled with promoter tuning and codon optimization, we developed the strain SQR2, which produced 269.9 mg/L riboflavin under bioreactor conditions without impairing bacterial growth. The enhanced riboflavin production substantially improved BES performance, increasing the current density and power output by 22.2- and 11.6-fold over the control, respectively. In hybrid BESs treating WAS, the introduction of the SQR2 strain further promoted electricity generation, reduced charge-transfer resistance, and selectively enhanced electroactive microbial taxa. Our study demonstrates a scalable, inducer-free strategy-from genetic design to process application-that strengthens sludge-based bioelectricity generation and supports sustainable wastewater resource recovery.

Background

This study addresses the challenge of limited extracellular electron transfer capacity in bioelectrochemical systems (BESs) used for converting organic matter in waste activated sludge (WAS) into electricity. Previous research has shown that enhancing electron transfer can improve BES performance, but achieving this efficiently remains difficult. The study is significant as it proposes a novel genetic engineering approach to enhance bioelectricity generation, which could contribute to sustainable energy recovery from wastewater.

Methods

The researchers engineered a quorum sensing-driven synthetic strategy to create a riboflavin-hyperproducing strain of Shewanella oneidensis, named SQR2. This involved modifying the Esa quorum-sensing circuit to autonomously control riboflavin biosynthesis, along with promoter tuning and codon optimization. The study evaluated the performance of this strain in bioelectrochemical systems treating waste activated sludge, measuring outcomes such as riboflavin production, current density, power output, and charge-transfer resistance.

Results

The engineered SQR2 strain produced 269.9 mg/L riboflavin under bioreactor conditions, significantly enhancing BES performance. The current density increased by 22.2-fold and power output by 11.6-fold compared to the control. The introduction of SQR2 in hybrid BESs treating WAS further promoted electricity generation and reduced charge-transfer resistance, selectively enhancing electroactive microbial taxa.

Interpretation

The study demonstrates a successful application of genetic engineering to improve BES performance by enhancing riboflavin production. While the increase in current density and power output is statistically significant, the clinical relevance is limited as the study focuses on microbial and bioelectrochemical processes rather than direct therapeutic applications. The scalability and practical implementation of this approach in real-world wastewater treatment settings remain to be fully evaluated.

Key findings

  • 269.9 mg/L riboflavin produced under bioreactor conditions.
  • 22.2-fold increase in current density over control.
  • 11.6-fold increase in power output over control.
  • Enhanced electricity generation in hybrid BESs treating WAS.
  • Reduced charge-transfer resistance with SQR2 strain.

Limitations

  • Microbial and bioelectrochemical focus, no direct clinical application.
  • Controlled environment may not reflect real-world conditions.
  • Limited to engineered bacterial strains.

Elsewhere in the Sermorelin corpus

BDiabetes-associated MYT1 and ST18 genes regulate human beta cell insulin secretion and survival via other diabetes risk genes.Diabetologia · 2026 · Enrichment of 2.05-fold relative to the random distribution of beta cell-expressed genes.HumanBGardnerella enrichment in the vaginal microbiome of women with gestational diabetes mellitus is associated with lower fetal birthweight percentiles.Diabetologia · 2026 · Gardnerella abundance was 9.7% in GDM vs 1.4% in controls, nominal p=0.011.HumanCReconstituting a two-step pathway for &lt;i&gt;N&lt;/i&gt;,&lt;i&gt;N&lt;/i&gt;-dimethyltryptamine (DMT) biosynthesis in bacteria.Metabolic engineering communications · 2026 · 103 mg/L DMT after 48 hours in complex medium.In vitroCImpact of secretome containing extracellular vesicles from human induced pluripotent stem cell-derived cardiomyocytes.Regenerative therapy · 2026 · Not reported in abstract.In vitroCMetabolic engineering of &lt;i&gt;Escherichia coli&lt;/i&gt; based on adaptive evolution and omics technology for highly efficient l-valine production under oxygen-limited conditions.Synthetic and systems biotechnology · 2026 · l-valine titer of 93.7 g/L within 28 h in a 5-L bioreactor.In vitroCIdentification of integration site library for the development of plasmid-free microbial cell factory in &lt;i&gt;Bacillus subtilis&lt;/i&gt;.Synthetic and systems biotechnology · 2026 · The highest expression site spxA was 1.89 times as high as amyE.In vitro